Quarterly report pursuant to Section 13 or 15(d)

Debt (Details)

Debt (Details)		1 Months Ended	3 Months Ended		6 Months Ended
Debt (Details)	Dec. 10, 2021 USD ($) $ / shares $ / item shares	Sep. 23, 2022	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Debt (Details) [Line Items]
Interest rate, percentage	8.00%
Fixed price of pe share (in Dollars per Item) \| $ / item	0.25
Common stock per share (in Dollars per share) \| $ / shares	$ 0.2
Conversion price (in Dollars per share) \| $ / shares	$ 0.0333		$ 0.1		$ 0.1
Warrant exercisable price (in Dollars per share) \| $ / shares					$ 0.125
Aggregate common Stock					$ 878,260
Warrants at issuance					$ 170,210
Risk-free interest rate					1.25%
Expected life					5 years
Expected volatility percentage					142.53%
Dividend yield percent					0.00%
Gross proceeds			$ 1,000,000		$ 1,000,000
Cash placement agent fees					100,000
Legal fees					15,192
Amortization expense			64,280	$ 0	69,256	$ 0
Accrued interest					39,452
Unpaid interest			6,995		$ 6,995		$ 4,831
Description of securities purchase agreement		On September 23, 2022, the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor, a Promissory Note (the “Promissory Note”) in the principal sum of $700,000.00, which amount is the $644,000 actual amount of the purchase price plus an original issue discount in the amount of $56,000. In connection with the issuance of the Promissory Note, the Company issued to the investor warrants to purchase 2,800,000 shares of common stock at an exercise price of $0.225, as well as returnable warrants (the “Returnable Warrants”), which may only be exercised in the event that the Company were to default on certain debt obligations, to purchase 7,000,000 shares of common stock at an exercise price of $0.30, in each case subject to adjustment. The Promissory Note may be converted into Company common stock in the event of an event of default under the Promissory Note by the Company.
Returnable Warrants term					5 years
Exercise Price (in Dollars per share) \| $ / shares					$ 0.3
Subject to adjustment price (in Dollars per share) \| $ / shares					$ 0.0333
Associated fees					$ 1,750
Prepayment					$ 750
Warrants description					Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. For example, as a result of the December 2021 Offering, which would allow the new noteholders to convert their debt to shares of common stock at an exercise price of $0.20/share, some of the $0.30 warrants outstanding in the table below had their exercise price reduced from $0.30 to $0.2919 which was further adjusted to $0.0747 prior to December 31, 2022 upon the occurrence of a further dilutive event. The result of the warrant exercise price downward adjustment on modification date was treated as a deemed dividend and fully amortized on the transaction date, and the Company recorded $3,685,665 to additional paid in capital and retained earnings on the Company’s balance sheets. In addition to the reduction in exercise price, there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
Commission fees					$ 604,800
Minimum [Member]
Debt (Details) [Line Items]
Interest expense					15,711
Maximum [Member]
Debt (Details) [Line Items]
Interest expense			14,311
Placement Agent [Member]
Debt (Details) [Line Items]
Aggregate common Stock					878,260
Cash commission			100,000		100,000
Promissory Notes [Member]
Debt (Details) [Line Items]
Cash placement agent fees					35,000
Legal fees					7,000
Debt discount			276,814		276,814			$ 0
Interest expense					$ 41,617	4,909
Warrants description					As a result of the financing, the Company is required to pay cash fees to its bankers (including the Placement Agent), which amounts are being determined but will not be less than $67,000, and to issue compensatory warrants to the Placement Agents to purchase 280,000 shares of common stock at an exercise price of $0.225, warrants to purchase 119,260 shares of common stock at an exercise price of $0.27, in each case subject to adjustment.
Commission fees					$ 32,200
convertible promissory note and a security purchase agreement [Member] \| Transaction Documents [Member]
Debt (Details) [Line Items]
Issued warrants (in Shares) \| shares					5,434,783
Convertible Notes Payable [Member]
Debt (Details) [Line Items]
Fixed price of pe share (in Dollars per Item) \| $ / item	0.2
Amortization expense			420,627	12,218	$ 960,197	$ 12,218
Debt discount			0		$ 0		$ 960,197
Interest expense			$ 20,071	$ 4,909
Convertible Notes Payable [Member] \| convertible promissory note and a security purchase agreement [Member]
Debt (Details) [Line Items]
Principal amount of discount	$ 1,086,956.52
Original issue discount	$ 1,000,000
Original discount, percentage	8.00%
Purchase of warrant (in Shares) \| shares	4,000,000
Notes payable interest rate	8.00%
Net proceeds amount	$ 500,000
Maturity date	Dec. 10, 2022
Convertible Notes Payable [Member] \| convertible promissory note and a security purchase agreement [Member] \| Common Stock [Member]
Debt (Details) [Line Items]
Warrant exercisable price (in Dollars per share) \| $ / shares					$ 0.25
Convertible Notes Payable [Member] \| convertible promissory note and a security purchase agreement [Member] \| Minimum [Member]
Debt (Details) [Line Items]
Notes payable interest rate	115.00%
Convertible Notes Payable [Member] \| convertible promissory note and a security purchase agreement [Member] \| Maximum [Member]
Debt (Details) [Line Items]
Notes payable interest rate	120.00%